• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconAstraZeneca

AstraZeneca

Page 10 of 13
Photo of CEPI Deputy Director Frederik Kristensen
HealthWhich COVID-19 vaccine works best? A new lab network promises an answer
By Jeremy KahnOctober 6, 2020
Vials of AstraZeneca's Covid-19 vaccine.
HealthWith AstraZeneca’s COVID-19 vaccine trials on hold in the U.S., a gulf widens between America and other countries
By Jeremy KahnOctober 2, 2020
Portrait of Pascal Soriot, AstraZeneca CEO
HealthUnder fire, AstraZeneca CEO defends transparency of COVID-19 vaccine trials
By Jeremy KahnSeptember 24, 2020
To jumpstart the COVID vaccine race, the U.K. considers ‘challenge trials’ exposing people to the virus
HealthTo jumpstart the COVID vaccine race, the U.K. considers ‘challenge trials’ exposing people to the virus
By James Paton and BloombergSeptember 24, 2020
‘The whole world is coming together’: How the race for a COVID vaccine is revolutionizing Big Pharma
Magazine‘The whole world is coming together’: How the race for a COVID vaccine is revolutionizing Big Pharma
By Clifton LeafSeptember 21, 2020
China’s Sinovac plans to test COVID vaccine on children before the company is sure the inoculation works in adults
HealthChina’s Sinovac plans to test COVID vaccine on children before the company is sure the inoculation works in adults
By Grady McGregor and Jeremy KahnSeptember 18, 2020
AstraZeneca’s COVID-19 vaccine is back on track after getting the green light to resume trials in the U.K.
HealthAstraZeneca’s COVID-19 vaccine is back on track after getting the green light to resume trials in the U.K.
By Stephanie Baker and BloombergSeptember 13, 2020
Coronavirus Vaccine Research at Valneva SA Labs
NewslettersThe rollercoaster of COVID-19 vaccines
By Sy MukherjeeSeptember 10, 2020
Close-up of someone receiving a vaccination.
HealthCOVID-19 vaccine still on track for later this year despite trial pause, AstraZeneca CEO says
By Jeremy KahnSeptember 10, 2020
Scientists see an upside to AstraZeneca halting its COVID-19 vaccine trial
Scientists see an upside to AstraZeneca halting its COVID-19 vaccine trial
By Grady McGregorSeptember 9, 2020
Global stocks climb—and futures jump—after Tuesday’s sell-off
NewslettersGlobal stocks climb—and futures jump—after Tuesday’s sell-off
By Bernhard WarnerSeptember 9, 2020
ARGENTINA-HEALTH-VIRUS-VACCINE-LABORATORY
Some scientists downplay significance of AstraZeneca’s COVID-19 vaccine trial halt
By Michelle Fay Cortez, Riley Griffin and BloombergSeptember 8, 2020
Image of a syringe injecting a coronavirus in front of an American flag.
HealthTrump wants a COVID-19 vaccine by Election Day. But will one be ready?
By Jeremy KahnSeptember 4, 2020
Woman in a white lab coat and pink rubber gloves holding a vial of purple liquid.
HealthScientists to Wall Street: You don’t really understand how COVID vaccine tests work
By Jeremy KahnAugust 24, 2020
Syringe shown against the AstraZeneca logo
HealthAstraZeneca denies it is in discussions to fast-track U.S. approval of its COVID-19 vaccine
By Jeremy KahnAugust 24, 2020
1...
  • 8
  • 9
  • 10
  • 11
  • 12
13
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.